|
TVIS44038264
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
195303203 |
195303203 |
q29 |
ENSG00000295476, ACAP2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038265
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
195303191 |
195303191 |
q29 |
ENSG00000295476, ACAP2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038266
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
194393635 |
194393635 |
q29 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038267
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
194393603 |
194393603 |
q29 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038268
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
189384160 |
189384160 |
q28 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038269
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
189384110 |
189384110 |
q28 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038270
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
189384078 |
189384078 |
q28 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038271
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
187696787 |
187696787 |
q27.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038272
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
187347541 |
187347541 |
q27.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038273
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr3 |
186859613 |
186859613 |
q27.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |